Publications by authors named "C van den Bos"

Immune checkpoint inhibition (ICI) has significantly advanced the field of immuno-oncology, yet not all patients benefit from this therapy. Combining ICI with other therapeutic modalities, including tumor ablation, is currently being explored as a method to enhance ICI efficacy. Mechanical High-Intensity Focused Ultrasound (M-HIFU) represents a promising tumor ablative therapy, inducing cavitation within the tumor, resulting in tumor cell destruction and the release of danger signals and tumor antigens, two key factors contributing to anti-tumor immune responses.

View Article and Find Full Text PDF
Article Synopsis
  • Juvenile xanthogranuloma (JXG) is a type of skin tumor mostly found in children, but some cases occur in other parts of the body, and their genetic causes are not fully understood.* -
  • A study analyzed 16 children and 5 adults with extracutaneous JXG using advanced sequencing, finding that numerous genetic alterations, especially related to kinase fusions, were present in most children.* -
  • The findings indicate that while surgery is common for treatment, some cases can regress on their own, and specific genetic alterations could help inform better treatment options in the future.*
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers used intestine-specific TRPM6 knockout mice to examine magnesium absorption after a 4-day omeprazole treatment, finding that these knockout mice had lower Mg absorption and serum levels compared to control mice.
  • * Ultimately, the results suggest that TRPM6 isn't impacted by short-term PPI use for magnesium absorption in the intestines, as no significant changes in magnesium homeostasis were observed.
View Article and Find Full Text PDF

Infections lead to substantial morbidity during the treatment of acute lymphoblastic leukemia (ALL) in which the adaptive immune system is severely affected, leading to declining serum immunoglobulin levels. We performed a trial to investigate whether intravenous immunoglobulin (IVIG) prophylaxis in pediatric patients with ALL could prevent admissions for fever. This randomized controlled trial was a subtrial of the national Dutch multicenter ALL study.

View Article and Find Full Text PDF